In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ross "Improved" Similac infant formula with increased nucleotides now launching.

This article was originally published in The Tan Sheet

Executive Summary

ROSS PRODUCTS "IMPROVED" SIMILAC INFANT FORMULA LAUNCHING NATIONWIDE in May with increased levels of nucleotides and a new fat blend and protein system, the Columbus, Ohio-based division of Abbott Labs said. Improved Similac infant formula contains 72 mg of nucleotides; "the level of nucleotides in any other infant less than half the total potentially available nucleotides found in improved Similac and breast milk," Ross stated. The reformulated product is replacing the former version.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts